冠昊生物最新筹码趋于集中

Summary of Key Points Core Viewpoint - Guanhao Biological has experienced a decline in the number of shareholders for the second consecutive period, indicating potential concerns regarding investor confidence and stock performance [2]. Financial Performance - For the first half of the year, the company reported a total revenue of 201 million yuan, representing a year-on-year growth of 5.89% [2]. - The net profit for the same period was approximately 20.4 million yuan, with a year-on-year increase of 1.27% [2]. - The basic earnings per share were recorded at 0.0800 yuan, and the weighted average return on net assets was 3.68% [2]. Shareholder Dynamics - As of August 31, the number of shareholders stood at 28,869, which is a decrease of 2,484 from the previous period (August 20), reflecting a month-on-month decline of 7.92% [2]. - The stock price closed at 16.80 yuan, showing a slight increase of 0.30%, but the cumulative decline since the concentration of shares began is 3.11% [2]. - The stock has experienced 4 days of increases and 4 days of decreases during the reporting period [2].